Atea Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Boston, MA
AVIR chart
What traders are saying about $AVIR
Latest postsAtea Pharmaceuticals, Inc. news
- Atea Pharma (AVIR) Q3 2026 Earnings Call Transcript
fool.com ·
- What Atea Pharmaceuticals (AVIR) Said on Its Q3 Earnings Call
marketbeat.com ·
- Atea Pharmaceuticals Q3FY26 Results: Cash $191.2M, New $200M Facility
scanx.trade ·
- Atea Pharmaceuticals, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Atea Pharmaceuticals Q3 2026 Earnings Call Transcript
Benzinga ·
- Atea Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- A hepatitis C treatment met its trial goals. Atea reported a 93.91% rate on the accepted cure measure.
Stock Titan ·
- Atea Pharmaceuticals Secures Up to $200 Million Credit Facility From Hercules Capital
marketscreener.com ·
- Atea Pharmaceuticals Secures Up to $200 Million in Financing
TipRanks ·
- Form 8K Atea Pharmaceuticals Inc For: 9 November By Investing.com
Investing.com Canada ·
- Atea Pharmaceuticals secures $200M credit facility from Hercules By Investing.com
Investing.com UK ·
- Atea Pharmaceuticals Secures Credit Facility for Up to $200 Million from Hercules Capital
Yahoo Finance ·
Atea Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$158.0M | -$168.0M | -$136.0M | -$116.0M |
| Diluted EPS | $-1.94 | $-2.00 | $-1.63 | $-1.39 |
| Total assets (year end) | $315.2M | $464.7M | $595.0M | $666.7M |
| Cash and equivalents (year end) | $95.7M | $64.7M | $143.8M | $188.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Atea Pharmaceuticals, Inc.
- Ticker
- AVIR (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, MA
- Incorporated in
- MA
- Fiscal year end
- December 31
- SEC CIK
- 1593899
Frequently asked questions
What exchange is Atea Pharmaceuticals, Inc. listed on?
Atea Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol AVIR.
What industry is Atea Pharmaceuticals, Inc. in?
Atea Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Atea Pharmaceuticals, Inc. headquartered?
Atea Pharmaceuticals, Inc.'s business address on file with the SEC is in Boston, MA.
When does Atea Pharmaceuticals, Inc.'s fiscal year end?
Atea Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Atea Pharmaceuticals, Inc. report?
Atea Pharmaceuticals, Inc. reported $351.4M in revenue for calendar year 2021, according to its SEC filings.